Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease.

[1]  M. Diani,et al.  T Helper Cell Subsets in Clinical Manifestations of Psoriasis , 2016, Journal of immunology research.

[2]  N. Shastri,et al.  Continuous Effector CD8(+) T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population. , 2016, Immunity.

[3]  F. Villanova,et al.  Targeting CD8(+) T cells prevents psoriasis development. , 2016, The Journal of allergy and clinical immunology.

[4]  F. Granucci,et al.  A role for CCR5(+)CD4 T cells in cutaneous psoriasis and for CD103(+) CCR4(+) CD8 Teff cells in the associated systemic inflammation. , 2016, Journal of autoimmunity.

[5]  Federica Sallusto,et al.  Heterogeneity of Human CD4(+) T Cells Against Microbes. , 2016, Annual review of immunology.

[6]  Scott N. Mueller,et al.  Skin CD4+ memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation , 2016, Nature Communications.

[7]  S. Krebs,et al.  Melanocyte antigen triggers autoimmunity in human psoriasis , 2015, The Journal of experimental medicine.

[8]  R. Emerson,et al.  Common clonal origin of central and resident memory T cells following skin immunization , 2015, Nature Medicine.

[9]  M. Diani,et al.  T cell responses in psoriasis and psoriatic arthritis. , 2015, Autoimmunity reviews.

[10]  Rei Watanabe,et al.  Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells , 2015, Science Translational Medicine.

[11]  B. Marinari,et al.  The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis , 2014, Nature Communications.

[12]  Sarah L. Gaffen,et al.  The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing , 2014, Nature Reviews Immunology.

[13]  G. Banfi,et al.  Differential expression of interleukin‐2 by anti‐CD3‐stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis , 2014, Clinical and experimental dermatology.

[14]  M. Ståhle,et al.  Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed Psoriasis , 2014, The Journal of Immunology.

[15]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[16]  Andrew Johnston,et al.  Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms , 2014, The Journal of investigative dermatology.

[17]  D. Farber,et al.  Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.

[18]  Scott N. Mueller,et al.  The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin , 2013, Nature Immunology.

[19]  C. Moscheni,et al.  Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis. , 2013, The American journal of pathology.

[20]  David A. Martin,et al.  The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. , 2013, Trends in immunology.

[21]  R. Clark,et al.  CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. , 2013, The Journal of investigative dermatology.

[22]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[23]  A. Hayday,et al.  Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis , 2011, The Journal of Immunology.

[24]  J. Krueger,et al.  Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. , 2011, The Journal of allergy and clinical immunology.

[25]  Gianfranco Altomare,et al.  Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. , 2011, Clinical immunology.

[26]  B. Bellosillo,et al.  Circulating CLA+ T cell subsets inversely correlate with disease severity and extension in acute psoriasis but not in chronic plaque psoriasis. , 2008, European journal of dermatology : EJD.

[27]  James T. Elder,et al.  Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis1 , 2008, The Journal of Immunology.

[28]  O. Boyman,et al.  α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis , 2007, Nature Medicine.

[29]  P. V. D. van de Kerkhof,et al.  Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late , 2004, The British journal of dermatology.

[30]  B. Ludviksson,et al.  The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease , 2001, Clinical and experimental immunology.

[31]  S. K. Szabo,et al.  Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. , 1998, The Journal of investigative dermatology.

[32]  L. Picker,et al.  Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). , 1995, Journal of immunology.

[33]  W. Jochum,et al.  T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.

[34]  Scott N. Mueller,et al.  Peripheral tissue surveillance and residency by memory T cells. , 2013, Trends in immunology.

[35]  A. Giménez-Arnau,et al.  Circulating CLA(+) T cells from acute and chronic psoriasis patients manifest a different activation state and correlation with disease severity and extension. , 2006, The Journal of investigative dermatology.

[36]  L. Santamaria-Babí.  CLA(+) T cells in cutaneous diseases. , 2004, European journal of dermatology : EJD.

[37]  K. Blaser,et al.  Skin-homing T cells in human cutaneous allergic inflammation , 1995, Immunologic research.